J Am Geriatr Soc 65(9):19881995 Rooks D, Swan T, Goswami B, Filosa LA, Bunte O, Panchaud N et al (2020) Bimagrumab vs optimized standard of care for treatment of sarcopenia in Community-Dwelling older adults: A randomized clinical trial
This combination therapy is expected to achieve a 15% reduction in body weight after 32 weeks, offering a significant improvement over existing treatments
Right now, theres no FDA-approved GLP-1 patch, Dr
In some areas, its clear that GLP-1s have clearly strong, positive effects on an individuals health and well-being (i.e., diabetes, obesity), and in other areas, its not yet clear, but we may soon find the same (i.e., neurological diseases)
Weight loss for general health or cosmetic purposes does not meet that standard
With bacteriostatic water, reconstituted Retatrutide typically remains stable for 28-30 days when properly refrigerated